Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Donate to our blog

Your support will help Science & Enterprise continue to provide science news for business people and business news for scientists.

Patent Issued for Peptides in Diabetes Gene Therapy

A U.S. patent was issued today for synthetic peptides that support gene therapies developed to treat type 2 diabetes and heart failure. . . . → Read More: Patent Issued for Peptides in Diabetes Gene Therapy

Low-Dose Multidrug Shown Effective in Hypertension Trial

A small-scale clinical trial shows a combination of four current drugs to treat hypertension, or high blood pressure, formulated in low doses, reduces blood pressure to normal levels in four weeks. . . . → Read More: Low-Dose Multidrug Shown Effective in Hypertension Trial

Company, NC State Partner on Tissue Oxygen Patch

Profusa Inc. and a research center at North Carolina State University are developing a new device to monitor tissue oxygen levels in people with peripheral artery disease. . . . → Read More: Company, NC State Partner on Tissue Oxygen Patch

EU Project to Develop More Versatile Heart Pacemakers

An initiative in Europe plans to design a new type of pacemaker device that adapts to a host of signals in the cardiovascular system and regulates multiple heart functions. . . . → Read More: EU Project to Develop More Versatile Heart Pacemakers

Lilly Acquires Migraine Therapy Company in $960M Deal

Drug maker Eli Lilly and Company is acquiring CoLucid Pharmaceuticals, a developer of treatments for migraine pain and associated symptoms. . . . → Read More: Lilly Acquires Migraine Therapy Company in $960M Deal

Pharma Firms Start Non-Communicable Disease Initiative

A group of 22 pharmaceutical companies is supporting worldwide projects to improve access to prevention and treatments for chronic disorders like cancer and heart disease, in lower-resource regions. . . . → Read More: Pharma Firms Start Non-Communicable Disease Initiative

Ionis Options Cardiac Drugs in $1.5 Billion Deal

Biotechnology company Ionis Pharmaceuticals is providing drug maker Novartis first access to two experimental drugs for controlling proteins that promote cholesterol and triglycerides, which contribute to heart disease. . . . → Read More: Ionis Options Cardiac Drugs in $1.5 Billion Deal

Solar Cells Shown Feasible to Power Medical Implants

Biomedical engineers in Switzerland built and field-tested small solar cells that generated enough energy for implanted medical devices like heart pacemakers. . . . → Read More: Solar Cells Shown Feasible to Power Medical Implants

Trial to Test Stem Cells for Treating Heart Failure

A clinical trial testing a treatment for heart failure using a patient’s own bone marrow stem cells is recruiting participants at the first two study sites. . . . → Read More: Trial to Test Stem Cells for Treating Heart Failure

Genetic Tests, Elec. Health Records Show Hidden Disease

A program that connects mass genetic screening to electronic health records shows a segment of the population tested has an undiagnosed blood disorder causing high cholesterol levels. . . . → Read More: Genetic Tests, Elec. Health Records Show Hidden Disease